C WorldWide Group Holding A S Sells 411 Shares of Waters Corporation $WAT

C WorldWide Group Holding A S cut its position in shares of Waters Corporation (NYSE:WAT) by 1.1% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 37,085 shares of the medical instruments supplier’s stock after selling 411 shares during the quarter. C WorldWide Group Holding A S’s holdings in Waters were worth $12,944,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in WAT. Swedbank AB boosted its position in shares of Waters by 25.8% in the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock worth $14,145,000 after purchasing an additional 8,305 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Waters by 5.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier’s stock valued at $195,599,000 after acquiring an additional 28,018 shares in the last quarter. Jacobs Levy Equity Management Inc. bought a new position in Waters in the 1st quarter valued at approximately $1,244,000. Mn Services Vermogensbeheer B.V. lifted its position in Waters by 7.0% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 22,933 shares of the medical instruments supplier’s stock valued at $8,005,000 after acquiring an additional 1,500 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in Waters by 12.6% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,021 shares of the medical instruments supplier’s stock valued at $2,800,000 after acquiring an additional 896 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Price Performance

NYSE WAT opened at $372.09 on Thursday. The business’s fifty day moving average price is $320.65 and its 200-day moving average price is $325.41. The stock has a market capitalization of $22.15 billion, a price-to-earnings ratio of 33.55, a PEG ratio of 3.19 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56.

Waters (NYSE:WAT) last released its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The firm had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. On average, equities analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently issued reports on WAT. Cowen reaffirmed a “hold” rating on shares of Waters in a research report on Wednesday. Robert W. Baird lowered their price objective on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 16th. Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a “buy” rating in a research report on Monday, August 4th. Finally, TD Cowen upped their price objective on Waters from $345.00 to $390.00 and gave the company a “hold” rating in a research report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, Waters currently has a consensus rating of “Moderate Buy” and an average price target of $381.57.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.